Search research articles
Contact Us
Filters
Showing results (71-80 of 129) with videos related to
Page
of 13
Sort By:
Haematologica
|
November 30, 2023
Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzumab in relapsed or refractory follicular lymphoma
Matthew J Maurer, Carla Casulo, Melissa C Larson, et al.
British Journal of Haematology
|
October 26, 2023
Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine-rituximab
Colleen A Ramsower, Allison Rosenthal, Ryan S Robetorye, et al.
Blood Advances
|
November 27, 2024
Treatment patterns and outcomes in follicular lymphoma with POD24: an analysis from the LEO Consortium
Jonathan R Day, Melissa C Larson, Urshila Durani, et al.
Blood Advances
|
February 22, 2023
A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma
Yazeed Sawalha, Subir Goyal, Jeffrey M Switchenko, et al.
Blood Cancer Journal
|
March 27, 2025
Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapy
Reem Karmali, Geoffrey Shouse, Pallawi Torka, et al.
British Journal of Haematology
|
September 28, 2021
Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation
Peter A Riedell, Mehdi Hamadani, Kwang W Ahn, et al.
The Lancet. Haematology
|
March 31, 2022
Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study
Carla Casulo, Melissa C Larson, Julianne J Lunde, et al.
Blood Advances
|
August 27, 2021
Multicenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphoma
Victor M Orellana-Noia, Krista Isaac, Mary-Kate Malecek, et al.
Blood
|
February 9, 2026
A Randomized Phase 2 Study of Ipilimumab, Nivolumab, and Brentuximab Vedotin in Patients with Relapsed Hodgkin Lymphoma
Catherine Diefenbach, Opeyemi Jegede, Victoria Wang, et al.
Hematological Oncology
|
October 7, 2025
Adaptation and Performance of the Self-Report-Generated Charlson Comorbidity Index in the Lymphoma Epidemiology of Outcomes (LEO) Cohort
James R Cerhan, Tereza Sokolova, Elliott J Cahn, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 129) with videos related to
Sort By:
Page
of 13
Haematologica
|
November 30, 2023
Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzumab in relapsed or refractory follicular lymphoma
Matthew J Maurer, Carla Casulo, Melissa C Larson, et al.
British Journal of Haematology
|
October 26, 2023
Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine-rituximab
Colleen A Ramsower, Allison Rosenthal, Ryan S Robetorye, et al.
Blood Advances
|
November 27, 2024
Treatment patterns and outcomes in follicular lymphoma with POD24: an analysis from the LEO Consortium
Jonathan R Day, Melissa C Larson, Urshila Durani, et al.
Blood Advances
|
February 22, 2023
A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma
Yazeed Sawalha, Subir Goyal, Jeffrey M Switchenko, et al.
Blood Cancer Journal
|
March 27, 2025
Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapy
Reem Karmali, Geoffrey Shouse, Pallawi Torka, et al.
British Journal of Haematology
|
September 28, 2021
Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation
Peter A Riedell, Mehdi Hamadani, Kwang W Ahn, et al.
The Lancet. Haematology
|
March 31, 2022
Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study
Carla Casulo, Melissa C Larson, Julianne J Lunde, et al.
Blood Advances
|
August 27, 2021
Multicenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphoma
Victor M Orellana-Noia, Krista Isaac, Mary-Kate Malecek, et al.
Blood
|
February 9, 2026
A Randomized Phase 2 Study of Ipilimumab, Nivolumab, and Brentuximab Vedotin in Patients with Relapsed Hodgkin Lymphoma
Catherine Diefenbach, Opeyemi Jegede, Victoria Wang, et al.
Hematological Oncology
|
October 7, 2025
Adaptation and Performance of the Self-Report-Generated Charlson Comorbidity Index in the Lymphoma Epidemiology of Outcomes (LEO) Cohort
James R Cerhan, Tereza Sokolova, Elliott J Cahn, et al.
Page
of 13